NCT07121348

Brief Summary

the clinical trial aims to evaluate efficency of different scaffolds in cases of regeneration

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Jul 2025Dec 2026

Study Start

First participant enrolled

July 28, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 4, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 13, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

1 year

First QC Date

August 4, 2025

Last Update Submit

August 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • apical closure assessed radiographically

    radiographic evaluation of apical closure as reduction or elimination of the apical opening of the root

    12 months after treatment

Study Arms (4)

Platelet Rich Fibrin (PRF only)

EXPERIMENTAL

patients will recieve canal disinfection followed by induction of bleeding and placement of platelet rich fibrin as the only scaffold before coronal sealing. platelet rich fibrin is obtained br removing the middle layer from a centrifuged blood sample and this is rich in platelets that play role in promoting tissue regeneration.

Procedure: Platelet rich fibrin

Mesoporous Silica Nanoparticles scaffold (MSN)

EXPERIMENTAL

patients will recieve canal disinfection followed by induction of bleeding and injection of this scaffold directly before coronal sealing. Mesoporous Silica Nanoparticles are biocompatible with high surface area that used as scaffold for enhancing the outcome.

Procedure: Platelet rich fibrin

Hyaluronic Acid Nanoparticles scaffold (HA)

EXPERIMENTAL

patients will recieve canal disinfection followed by induction of bleeding and injection of this scaffold directly before coronal sealing. Hyalornic Acid nanoparticles are biodegradable with high water retention capacity promoting pulp tissue regeneration.

Procedure: Platelet rich fibrin

Pomegranate ( punica granatum) Extract Nanoparticles scaffold

EXPERIMENTAL

patients will recieve canal disinfection followed by induction of bleeding and injection of this scaffold directly before coronal sealing. Pomegranate Extract Nanoparticles are synthesized from Punica granatum exract with potential antimicrobial and regenerative properties.

Procedure: Platelet rich fibrin

Interventions

platelet rich fibrin is obtained by removing the middle layer from a centrifuged blood sample and is rich with platelets that plays an important role in tissue regeneration mesoporous silica nanoparticles are high surface area and excellent biocompatibility and enhance the outcome hyalurnic acid nanoparticles are high water capacity and involved in cell proliferation and adhesion and help in tissue regeneration pomegranate nanoparticles has anti-inflammatory and antibacterial effect and also help in tissue proliferation and regeneration

Also known as: mesoporous silica nanoparticles, hyaluronic acid nanoparticles, pomegranate (punica granatum) nanoparticles
Hyaluronic Acid Nanoparticles scaffold (HA)Mesoporous Silica Nanoparticles scaffold (MSN)Platelet Rich Fibrin (PRF only)Pomegranate ( punica granatum) Extract Nanoparticles scaffold

Eligibility Criteria

Age9 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Maxillary traumatized or cariously exposed non-vital immature anterior teeth.
  • Teeth don't need for post and core as a final restoration.
  • Radiographic evidence of an apical opening width more than 2 mm with or without periapical radiolucency.
  • Teeth without anatomical variations

You may not qualify if:

  • Teeth with previous endodontic treatment.
  • Teeth with internal or external resorption
  • Radiographic evidence of root fracture.
  • Lack of patient and parent cooperation.
  • Presence of periodontal pocket depth more than 4 mm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry,Tanta University

Tanta, Gharbia Governorate, Egypt

Location

Related Links

MeSH Terms

Interventions

Nanoparticles

Intervention Hierarchy (Ancestors)

NanostructuresManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Effect of Different NanoScaffolds on Pulp Regeneration in Non-Vital Immature Permanent Teeth (Randomized Clinical Trial)

Study Record Dates

First Submitted

August 4, 2025

First Posted

August 13, 2025

Study Start

July 28, 2025

Primary Completion (Estimated)

July 28, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 13, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

share clinical and radiograpjic outcomes with qualified researches

Shared Documents
STUDY PROTOCOL
Time Frame
starting 6 months after publication of the primary results and available for 2 years
Access Criteria
shared with qualified researchers upon reasonable request. requests should include a proposal outlining the intended use of the data
More information

Available IPD Datasets

Study Protocol (END-7-25-3400)Access

Locations